FDA Regulatory Compliance Attorneys
Firm Overview
Our People
News
Contact Us

FDA & Cosmetic Law

criminal defense

Customs & Trade Law

criminal defense

Complex Litigation

criminal defense

Criminal Defense

Criminal Defense

Providing a Vigorous Defense with Regulatory, Corporate and Tax Cases

The Federal Bureau of Investigation defines white collar crime as "illegal acts which are characterized by deceit, concealment, or violation of trust and which are not dependent upon the application or threat of physical force or violence." 

Criminal defense often involves charges of:

  • Bribery;
  • Computer fraud;
  • Corporate fraud;
  • Counterfeiting;
  • Embezzlement;
  • Environmental law violations;
  • Financial crimes;
  • Healthcare fraud;
  • Identity theft;
  • Insider trading;
  • Insurance fraud;
  • Money laundering;
  • Mortgage fraud;
  • Public corruption;
  • Tax evasion;
  • Telemarketing fraud;
  • Securities & Commodities fraud

Today, both the prosecution and the defense of white collar criminals has become a specialized practice area for attorneys across the country. White collar crimes are notoriously difficult to prosecute since they usually involve intelligent, educated perpetrators who have hidden their scams behind sophisticated shields, which may involve numerous companies, subsidiaries, and complex transactions. 

The white collar crime defense attorneys at C. Humphrey & Associates P.A. are ideal representatives for this sort of case. Our overlapping  practices of corporate, tax and regulatory law give us detailed knowledge of both the government and private/corporate perspective in white collar crime matters. We know how to mount a vigorous defense and fight for our clients' rights.


What's New at the FDA

FDA approves generic versions of blood thinner Plavix
May 17 2012 | 12:04 pm

FDA expands use for FilmArray Respiratory Panel
May 15 2012 | 11:29 am

FDA issues alert on potential dangers of unproven treatment for multiple sclerosis
May 10 2012 | 6:58 am



FDA Drug News

New and Generic Drug Approvals
May 17 2012 | 2:17 pm

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)
May 17 2012 | 8:06 am

Updated Questions and Answers for Healthcare Professionals and the Public: Use an Approved Pancreatic Enzyme Product (PEP)
May 17 2012 | 6:56 am

criminal defense